Previous close | 46.11 |
Open | 46.11 |
Bid | 59.60 |
Ask | 64.40 |
Strike | 30.00 |
Expiry date | 2024-07-19 |
Day's range | 46.11 - 46.11 |
Contract range | N/A |
Volume | |
Open interest | 1 |
On April 29, 2024, Michael Brophy, the Chief Financial Officer of Natera Inc (NASDAQ:NTRA), sold 1,238 shares of the company.
On April 29, 2024, Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), sold 4,084 shares of the company.
AUSTIN, Texas, May 01, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its first quarter ended March 31, 2024, after the market close on May 9, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).